CagriSema 12

Ebs Pharma Sa
Cagrisema 12 contains 6 mg of Semaglutide and 6mg of Cagrilintide per Vial.
2mg per week dosage
5 Week Supply
Once A Week Injection
Cagrisema is a medicine for weight loss and weight maintenance that contains the active substance Semaglutide and Cagrilintide. Semaglutide is similar to a natural hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after a meal. Semaglutide works by acting on receptors in the brain that control your appetite, causing you to feel fuller and less hungry and experience less craving for food. This will help you eat less food and reduce your body weight. Cagrilintide is a long-acting amylin analogue that is currently being investigated for its potential use in the treatment of obesity and related metabolic conditions. It mimics the effects of the natural hormone amylin. When both Semaglutide and Cagrilinitide are used together the overall efficacy is enhanced greatly. The most apparent result will be enhanced weightloss much greater than that of Semaglutide on its own.
This product contains both Semaglutide and Cagrlintide. 
Tell your doctor, pharmacist or nurse if you are using, have recently used or might use any other medicines.
Pregnancy and breast-feeding
This medicine should not be used during pregnancy, as it is not known if it may affect your unborn child. Therefore, it is recommended to use contraception while using this medicine. If you wish to become pregnant, you should stop using this medicine at least two months in advance. If you become or are pregnant, think you may be pregnant or are planning to have a baby when using this medicine, talk to your doctor straight away, as your treatment will need to be stopped.
You should not use this medicine if you are breast-feeding, as it is unknown if it passes into breast milk.
Driving and using machines
Cagrisema is unlikely to affect your ability to drive and use machines. Some patients may feel dizzy when taking Cagrisema mainly during the first 3 months of treatment (see section 4). If you feel dizzy you should not drive or operate machines until you feel better. If you need any further information, talk to your doctor, pharmacist or nurse.
For diabetics using this medicine in combination with a sulfonylurea or insulin, low blood sugar (hypoglycaemia) may occur which may reduce your ability to concentrate. Do not drive or use machines if you get any signs of low blood sugar. See section 2, ?Warning and precautions’ for information on increased risk of low blood sugar and section 4 for the warning signs of low blood sugar. Talk to your doctor for further information